MA44264A - Composition pharmaceutique orale d'isotrétinoïne - Google Patents

Composition pharmaceutique orale d'isotrétinoïne

Info

Publication number
MA44264A
MA44264A MA044264A MA44264A MA44264A MA 44264 A MA44264 A MA 44264A MA 044264 A MA044264 A MA 044264A MA 44264 A MA44264 A MA 44264A MA 44264 A MA44264 A MA 44264A
Authority
MA
Morocco
Prior art keywords
isotretinoin
pharmaceutical composition
oral pharmaceutical
oral
composition
Prior art date
Application number
MA044264A
Other languages
English (en)
Inventor
Pankaj Prabhakar AMRUTKAR
Subodh Deshmukh
Ravi Kochhar
Sumit Madan
Original Assignee
Sun Pharmaceutical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Ind Ltd filed Critical Sun Pharmaceutical Ind Ltd
Priority to MA044264A priority Critical patent/MA44264A/fr
Publication of MA44264A publication Critical patent/MA44264A/fr

Links

MA044264A 2015-05-29 2015-05-29 Composition pharmaceutique orale d'isotrétinoïne MA44264A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MA044264A MA44264A (fr) 2015-05-29 2015-05-29 Composition pharmaceutique orale d'isotrétinoïne

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA044264A MA44264A (fr) 2015-05-29 2015-05-29 Composition pharmaceutique orale d'isotrétinoïne

Publications (1)

Publication Number Publication Date
MA44264A true MA44264A (fr) 2019-01-09

Family

ID=77520379

Family Applications (1)

Application Number Title Priority Date Filing Date
MA044264A MA44264A (fr) 2015-05-29 2015-05-29 Composition pharmaceutique orale d'isotrétinoïne

Country Status (1)

Country Link
MA (1) MA44264A (fr)

Similar Documents

Publication Publication Date Title
DK3529248T3 (da) Farmaceutiske sammensætninger
MA41265A (fr) Compositions pour administration de médicaments iléo-jéjunal.
DK3297605T3 (da) Topiske, farmaceutiske sammesætninger
DK3116491T3 (da) Farmaceutiske sammensætninger af terapeutisk aktive forbindelser
MA47816A (fr) Composition pharmaceutique comprenant du sélexipag
MA50541A (fr) Formulations pharmaceutiques
DK3532029T3 (da) Flydende farmaceutisk sammensætning
DK3529240T3 (da) Farmaceutiske forbindelser
MA42303A (fr) Formulations pharmaceutiques
DK3634377T3 (da) Farmaceutisk formulering
MA40781A (fr) Composition pharmaceutique d'isotrétinoïne à faible dosage destinée à la voie orale
MA46867A (fr) Formulations pharmaceutiques
FR3022462B1 (fr) Composition orale d'anticorps anti-tnfalpha
DK3709978T3 (da) Farmaceutisk oral formulering omfattende bakterier
MA43705A (fr) Formulation pharmaceutique
DK3821905T3 (da) Insulin indeholdende farmaceutiske sammensætninger
MA47516A (fr) Composition pharmaceutique
DK3278801T3 (da) Farmaceutisk sammensætning indeholdende mirabegron
MA49837A (fr) Compositions pharmaceutiques
DK3544584T3 (da) Farmaceutisk parenteral formulering indeholdende cargluminsyre
DK3672631T3 (da) Farmaceutiske sammensætninger indeholdende anti-beta-amyloid-antistoffer
MA45158A (fr) Composition pharmaceutique comprenant de l'éteplirsen
DK3313370T3 (da) Oftalmologisk farmaceutisk sammensætning
DK3280447T3 (da) Farmaceutiske formuleringer
EP3302438A4 (fr) Composition pharmaceutique orale d'isotrétinoïne